Literature DB >> 9361598

Importance of microperineural invasion as a prognostic factor in ampullary carcinoma.

T Nakai1, K Koh, T Kawabe, E Son, H Yoshikawa, M Yasutomi.   

Abstract

BACKGROUND: This was a study of the relation of clinicopathological factors to prognosis in 25 patients who had ampullary carcinoma resected.
METHODS: The 5-year survival rate was six of the 25 patients. The presence of microperineural invasion was sought and related to outcome.
RESULTS: Factors relating to prognosis included tumour gross appearance, diameter, pancreatic invasion and microperineural invasion. The 5-year survival rate of 14 patients with microperineural invasion was 3, significantly worse than the 7 in 11 without invasion (P = 0.002, univariate analysis). By multivariate analysis, microperineural invasion was the most important prognostic factor (P = 0.02). Type of tumour recurrence was similar to that in pancreatic carcinoma.
CONCLUSION: Pancreaticoduodenectomy, rather than local resection, is the procedure of choice in patients with ampullary carcinoma.

Entities:  

Mesh:

Year:  1997        PMID: 9361598

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.

Authors:  Takeshi Sudo; Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Yasushi Hashimoto; Hiroki Ohge; Fumio Shimamoto; Taijiro Sueda
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

2.  Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion.

Authors:  John W C Chen; Mayank Bhandari; David S Astill; Thomas G Wilson; Lilian Kow; Mark Brooke-Smith; James Toouli; Robert T A Padbury
Journal:  HPB (Oxford)       Date:  2010-03       Impact factor: 3.647

3.  Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater.

Authors:  Laurence Chiche; Barbara Alkofer; Jean-Jacques Parienti; Vincent Rouleau; Ephrem Salamé; Guy Samama; Philippe Segol
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

4.  Predictors of survival in periampullary cancers following pancreaticoduodenectomy.

Authors:  Ioannis Hatzaras; Nathaniel George; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2010-01-28       Impact factor: 5.344

Review 5.  Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Elie El Rassy; Fady Ghassan Haddad; Colette Hanna; Fadi El Karak; Dolly Nasr
Journal:  World J Gastrointest Oncol       Date:  2016-10-15

6.  Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.

Authors:  Calogero Iacono; Giuseppe Verlato; Giuseppe Zamboni; Aldo Scarpa; Ettore Montresor; Paola Capelli; Luca Bortolasi; Giovanni Serio
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

7.  Prognostic Value of the Metastatic Lymph Node Ratio in Patients With Resectable Carcinoma of Ampulla of Vater.

Authors:  Chih-Ho Hsu; Tai-Di Chen; Chun-Yi Tsai; Jun-Te Hsu; Chun-Nan Yeh; Yi-Yin Jan; Ta-Sen Yeh; Wen-Chi Chou; Keng-Hao Liu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.